Patent ID: 9138442
Filing Date: 2015-09-22
Classification: A61K,A61P,C07H,Y02A

Abstract:
1. A method of treating HCV comprising administering a compound having the formula III: or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, solvate, or combination thereof, wherein: M′ and M″ are each independently selected from CH X′ is O, NH, NR″, or S; Y′ is, NHR Z′ and Z″ are each independently O, NR R and R′ are each independently H, OH, O-alkyl, O-aryl, O-heteroaryl, O-aralkyl, O-alkyl heteroaryl, —NH B Q′ is absent, or  wherein A is OH, O-alkyl, O-aryl, O-heteroaryl, O-aralkyl, or O-alkyl heteroaryl.